Profund Advisors LLC Grows Position in Intuitive Surgical, Inc. $ISRG

Profund Advisors LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,270 shares of the medical equipment provider’s stock after purchasing an additional 4,007 shares during the quarter. Intuitive Surgical comprises 0.6% of Profund Advisors LLC’s investment portfolio, making the stock its 23rd largest holding. Profund Advisors LLC’s holdings in Intuitive Surgical were worth $17,536,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the business. Nuveen LLC acquired a new position in Intuitive Surgical in the 1st quarter valued at about $1,715,899,000. Goldman Sachs Group Inc. grew its stake in shares of Intuitive Surgical by 26.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock valued at $1,396,496,000 after purchasing an additional 584,375 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after purchasing an additional 566,979 shares during the last quarter. Jennison Associates LLC raised its stake in shares of Intuitive Surgical by 20.4% during the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after purchasing an additional 528,359 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have issued reports on ISRG. Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. HSBC boosted their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Rothschild & Co Redburn boosted their target price on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, Daiwa Capital Markets raised their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 7,562 shares of the firm’s stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the sale, the executive vice president owned 353 shares in the company, valued at $193,595.79. This trade represents a 95.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 98,078 shares of company stock worth $51,445,892 in the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Trading Up 2.2%

ISRG stock opened at $560.00 on Friday. The firm has a 50 day moving average of $471.89 and a 200-day moving average of $501.02. The company has a market cap of $200.75 billion, a price-to-earnings ratio of 74.07, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period last year, the business posted $1.84 EPS. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.